ACUTA CAPITAL PARTNERS, LLC Hedge Fund

CIK: 0001582844 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 16, 2021

Total Value ($000): $250,241 (100.0% shares, 0.0% debt)

Holdings (38)

— VISTAGEN THERAPEUTICS INC 14.8%

Value ($000) $36,943 Shares 11,728,033 Est. Cost $2.01 Unrealized —

CLDX CELLDEX THERAPEUTICS INC NEW 13.2%

Value ($000) $33,019 Shares 987,406 Est. Cost $7.56 Unrealized +263.2%

CLDX CELLDEX THERAPEUTICS INC NEW 6.7%

Value ($000) $16,720 Shares 500,000 Est. Cost $7.56 Unrealized +263.2%

APLS APELLIS PHARMACEUTICALS INC 4.1%

Value ($000) $10,144 Shares 160,500 Est. Cost $35.31 Unrealized +46.1%

ARWR ARROWHEAD PHARMACEUTICALS IN 3.6%

Value ($000) $8,945 Shares 108,000 Est. Cost $40.37 Unrealized +84.4%

— BCLS ACQUISITION CORP 3.5%

Value ($000) $8,878 Shares 843,122 Est. Cost $11.14 Unrealized —

— VERASTEM INC 3.3%

Value ($000) $8,215 Shares 2,018,433 Est. Cost $2.55 Unrealized —

— IVERIC BIO INC 3.2%

Value ($000) $7,888 Shares 1,250,000 Est. Cost $6.17 Unrealized —

XENE XENON PHARMACEUTICALS INC 3.1%

Value ($000) $7,772 Shares 417,409 Est. Cost $15.28 Unrealized +20.6%

— SEELOS THERAPEUTICS INC 3.0%

Value ($000) $7,550 Shares 2,860,000 Est. Cost $4.05 Unrealized —

KURA KURA ONCOLOGY INC 2.9%

Value ($000) $7,368 Shares 353,398 Est. Cost $15.54 Unrealized +59.8%

— ESSA PHARMA INC 2.7%

Value ($000) $6,654 Shares 232,896 Est. Cost $29.05 Unrealized —

— CLEARSIDE BIOMEDICAL INC 2.6%

Value ($000) $6,410 Shares 1,316,268 Est. Cost $2.22 Unrealized —

FULC FULCRUM THERAPEUTICS INC 2.5%

Value ($000) $6,331 Shares 604,074 Est. Cost $11.72 Unrealized -13.7%

— VINCERX PHARMA INC 2.5%

Value ($000) $6,214 Shares 478,401 Est. Cost $18.19 Unrealized —

— CYTEIR THERAPEUTICS INC 2.4%

Value ($000) $5,944 Shares 277,777 Est. Cost $21.40 Unrealized —

— JIYA ACQUISITION CORP 2.2%

Value ($000) $5,591 Shares 562,500 Est. Cost $10.30 Unrealized —

— ATHIRA PHARMA INC 1.7%

Value ($000) $4,373 Shares 427,060 Est. Cost $19.07 Unrealized —

— ALIGOS THERAPEUTICS INC 1.7%

Value ($000) $4,368 Shares 214,254 Est. Cost $20.39 Unrealized —

— SELECTA BIOSCIENCES INC 1.7%

Value ($000) $4,283 Shares 1,024,668 Est. Cost $4.46 Unrealized —

— CHIMERIX INC 1.6%

Value ($000) $4,073 Shares 509,164 Est. Cost $9.64 Unrealized —

— HEALTH SCIENCES ACQ CORP 2 1.6%

Value ($000) $4,004 Shares 392,500 Est. Cost $11.00 Unrealized —

IOVA IOVANCE BIOTHERAPEUTICS INC 1.6%

Value ($000) $3,890 Shares 149,495 Est. Cost $19.45 Unrealized +33.6%

— AVADEL PHARMACEUTICALS PLC 1.5%

Value ($000) $3,776 Shares 561,011 Est. Cost $8.15 Unrealized —

SNDX SYNDAX PHARMACEUTICALS INC 1.4%

Value ($000) $3,539 Shares 206,126 Est. Cost $17.89 Unrealized +2.4%

EYPT EYEPOINT PHARMACEUTICALS INC 1.3%

Value ($000) $3,325 Shares 369,863 Est. Cost $11.25 Unrealized -14.7%

GHRS GH RESEARCH PLC 1.3%

Value ($000) $3,260 Shares 150,000 Est. Cost $20.43 Unrealized 0.0%

ACRS ACLARIS THERAPEUTICS INC 1.2%

Value ($000) $3,073 Shares 175,000 Est. Cost $19.56 Unrealized +16.2%

— CATALYST BIOSCIENCES INC 1.2%

Value ($000) $2,966 Shares 685,000 Est. Cost $4.48 Unrealized —

— SAGE THERAPEUTICS INC 1.2%

Value ($000) $2,894 Shares 50,945 Est. Cost $64.18 Unrealized —

— RAIN THERAPEUTICS INC 1.0%

Value ($000) $2,521 Shares 162,245 Est. Cost $15.54 Unrealized —

— CATABASIS PHARMACEUTICALS IN 1.0%

Value ($000) $2,476 Shares 1,173,674 Est. Cost $2.11 Unrealized —

CPRX CATALYST PHARMACEUTICALS INC 0.8%

Value ($000) $1,893 Shares 329,134 Est. Cost $4.88 Unrealized +5.8%

RNAM AVIDITY BIOSCIENCES INC 0.6%

Value ($000) $1,483 Shares 60,000 Est. Cost $28.88 Unrealized -19.4%

— REATA PHARMACEUTICALS INC 0.6%

Value ($000) $1,415 Shares 10,000 Est. Cost $99.71 Unrealized —

— CYMABAY THERAPEUTICS INC 0.5%

Value ($000) $1,316 Shares 301,904 Est. Cost $7.24 Unrealized —

NVAX NOVAVAX INC 0.2%

Value ($000) $491 Shares 2,315 Est. Cost $125.15 Unrealized +46.4%

— NUVATION BIO INC 0.1%

Value ($000) $236 Shares 90,832 Est. Cost $2.67 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	VISTAGEN THERAPEUTICS INC	11,728,033	$36,943	14.8%	$2.01	—	COM NEW	92840H202
CLDX	CELLDEX THERAPEUTICS INC NEW	987,406	$33,019	13.2%	$7.56	+263.2%	COM NEW	15117B202
CLDX	CELLDEX THERAPEUTICS INC NEW	500,000	$16,720	6.7%	$7.56	+263.2%	Put	15117B202
APLS	APELLIS PHARMACEUTICALS INC	160,500	$10,144	4.1%	$35.31	+46.1%	COM	03753U106
ARWR	ARROWHEAD PHARMACEUTICALS IN	108,000	$8,945	3.6%	$40.37	+84.4%	COM	04280A100
—	BCLS ACQUISITION CORP	843,122	$8,878	3.5%	$11.14	—	COM CL A	G0904B105
—	VERASTEM INC	2,018,433	$8,215	3.3%	$2.55	—	COM	92337C104
—	IVERIC BIO INC	1,250,000	$7,888	3.2%	$6.17	—	COM	46583P102
XENE	XENON PHARMACEUTICALS INC	417,409	$7,772	3.1%	$15.28	+20.6%	COM	98420N105
—	SEELOS THERAPEUTICS INC	2,860,000	$7,550	3.0%	$4.05	—	COM	81577F109
KURA	KURA ONCOLOGY INC	353,398	$7,368	2.9%	$15.54	+59.8%	COM	50127T109
—	ESSA PHARMA INC	232,896	$6,654	2.7%	$29.05	—	COM NEW	29668H708
—	CLEARSIDE BIOMEDICAL INC	1,316,268	$6,410	2.6%	$2.22	—	COM	185063104
FULC	FULCRUM THERAPEUTICS INC	604,074	$6,331	2.5%	$11.72	-13.7%	COM	359616109
—	VINCERX PHARMA INC	478,401	$6,214	2.5%	$18.19	—	COM NEW	92731L106
—	CYTEIR THERAPEUTICS INC	277,777	$5,944	2.4%	$21.40	—	COM	23284P103
—	JIYA ACQUISITION CORP	562,500	$5,591	2.2%	$10.30	—	COM CL A	47760M102
—	ATHIRA PHARMA INC	427,060	$4,373	1.7%	$19.07	—	COM	04746L104
—	ALIGOS THERAPEUTICS INC	214,254	$4,368	1.7%	$20.39	—	COM	01626L105
—	SELECTA BIOSCIENCES INC	1,024,668	$4,283	1.7%	$4.46	—	COM	816212104
—	CHIMERIX INC	509,164	$4,073	1.6%	$9.64	—	COM	16934W106
—	HEALTH SCIENCES ACQ CORP 2	392,500	$4,004	1.6%	$11.00	—	ORD SHS	G4411D109
IOVA	IOVANCE BIOTHERAPEUTICS INC	149,495	$3,890	1.6%	$19.45	+33.6%	COM	462260100
—	AVADEL PHARMACEUTICALS PLC	561,011	$3,776	1.5%	$8.15	—	SPONSORED ADR	05337M104
SNDX	SYNDAX PHARMACEUTICALS INC	206,126	$3,539	1.4%	$17.89	+2.4%	COM	87164F105
EYPT	EYEPOINT PHARMACEUTICALS INC	369,863	$3,325	1.3%	$11.25	-14.7%	COM NEW	30233G209
GHRS	GH RESEARCH PLC	150,000	$3,260	1.3%	$20.43	0.0%	ORDINARY SHARES	G3855L106
ACRS	ACLARIS THERAPEUTICS INC	175,000	$3,073	1.2%	$19.56	+16.2%	COM	00461U105
—	CATALYST BIOSCIENCES INC	685,000	$2,966	1.2%	$4.48	—	COM NEW	14888D208
—	SAGE THERAPEUTICS INC	50,945	$2,894	1.2%	$64.18	—	COM	78667J108
—	RAIN THERAPEUTICS INC	162,245	$2,521	1.0%	$15.54	—	COM	75082Q105
—	CATABASIS PHARMACEUTICALS IN	1,173,674	$2,476	1.0%	$2.11	—	COM NEW	14875P206
CPRX	CATALYST PHARMACEUTICALS INC	329,134	$1,893	0.8%	$4.88	+5.8%	COM	14888U101
RNAM	AVIDITY BIOSCIENCES INC	60,000	$1,483	0.6%	$28.88	-19.4%	COM	05370A108
—	REATA PHARMACEUTICALS INC	10,000	$1,415	0.6%	$99.71	—	CL A	75615P103
—	CYMABAY THERAPEUTICS INC	301,904	$1,316	0.5%	$7.24	—	COM	23257D103
NVAX	NOVAVAX INC	2,315	$491	0.2%	$125.15	+46.4%	COM NEW	670002401
—	NUVATION BIO INC	90,832	$236	0.1%	$2.67	—	*W EXP 07/07/202	67080N119